While this is less than semaglutide or tirzepatide, the value of cagrilintide is not as a standalone compound
If you want GLP-1 medication for weight management, say so clearly
Nutr Metab Cardiovasc Dis (2020) 30(10):162232
represent a promising advancement in GLP-1 receptor research
The NHS advises that individuals seeking weight loss should focus on evidence-based approaches, including reducing calorie intake, increasing physical activity, and accessing support through services such as the NHS Weight Loss Plan or local weight management programmes
Additional insights from the reports include: The most common eligibility requirements used to approve GLP-1 coverage are minimum body mass index (BMI) (90% corporate and 86% multiemployer and public employer), obesity with one other chronic disease (54% and 51%), and participating in a lifestyle modification program (29% and 34%)